5/17
07:44 am
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $14.00 price target on the stock.
Medium
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $14.00 price target on the stock.
5/17
05:35 am
capr
Rating for CAPR
Medium
Report
Rating for CAPR
5/17
05:35 am
capr
Rating for CAPR
Medium
Report
Rating for CAPR
5/14
02:20 pm
capr
Rating for CAPR
Low
Report
Rating for CAPR
5/14
09:30 am
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $8.00 price target on the stock.
Low
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $8.00 price target on the stock.
5/14
08:57 am
capr
Rating for CAPR
Medium
Report
Rating for CAPR
5/14
08:06 am
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Medium
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
4/25
08:01 am
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Low
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
3/1
08:14 am
capr
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Low
Report
Capricor Therapeutics Inc (NASDAQ: CAPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.